PUBLISHER: The Business Research Company | PRODUCT CODE: 1947118
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947118
Sequencing consumables encompass the reagents, kits, and materials utilized during DNA or RNA sequencing. These essential items are used for preparing, amplifying, and analyzing genetic samples within sequencing workflows. Designed to be compatible with specific sequencing platforms and technologies, sequencing consumables ensure the accuracy, efficiency, and reliability of genomic data generation.
The primary components of sequencing consumables include kits, reagents, and accessories. Sequencing kits are laboratory resources comprising essential reagents and protocols for DNA or RNA sequencing procedures. These consumables span across first-generation, second-generation, and third-generation sequencing platforms, serving various applications such as cancer diagnostics, infectious disease diagnostics, reproductive health diagnostics, pharmacogenomics, agrigenomics, among others. End-users, including pharmaceutical and biotechnology firms, hospitals, laboratories, academic research institutions, and others, utilize these consumables.
Tariffs are impacting the sequencing consumables market by increasing costs of imported enzymes, reagents, primers, sequencing chips, and specialty chemicals required for DNA and RNA sequencing workflows. Pharmaceutical companies, research laboratories, and hospitals in North America and Europe are most affected due to reliance on globally sourced consumables, while Asia-Pacific faces export-related cost pressures. These tariffs are raising operational costs and affecting research budgets. However, they are also promoting local reagent manufacturing, regional supply chain diversification, and increased investment in domestic genomics consumable production.
The sequencing consumables market research report is one of a series of new reports from The Business Research Company that provides sequencing consumables market statistics, including sequencing consumables industry global market size, regional shares, competitors with a sequencing consumables market share, detailed sequencing consumables market segments, market trends and opportunities, and any further data you may need to thrive in the sequencing consumables industry. This sequencing consumables market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The sequencing consumables market size has grown exponentially in recent years. It will grow from $12.36 billion in 2025 to $15.66 billion in 2026 at a compound annual growth rate (CAGR) of 26.7%. The growth in the historic period can be attributed to expansion of genomic research activities, growing adoption of sequencing in clinical diagnostics, increased funding for life sciences research, wider availability of sequencing platforms, rising use of consumables in oncology studies.
The sequencing consumables market size is expected to see exponential growth in the next few years. It will grow to $36.6 billion in 2030 at a compound annual growth rate (CAGR) of 23.6%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, expansion of infectious disease genomics, growing adoption of third-generation sequencing technologies, rising investments in genomic data analysis, increasing use of sequencing in population health studies. Major trends in the forecast period include increasing demand for high-throughput sequencing consumables, rising adoption of next-generation sequencing kits, growing use of specialized reagents for precision diagnostics, expansion of platform-specific consumable portfolios, enhanced focus on workflow efficiency and accuracy.
The anticipated increase in the prevalence of genetic diseases is poised to drive the expansion of the sequencing consumables market in the foreseeable future. Genetic diseases denote disorders arising from abnormalities in an individual's DNA or genes, often inherited from their parents. This upward trend in genetic disease prevalence is credited to factors such as heightened awareness, enhanced diagnostics, and evolving environmental conditions. Sequencing consumables play a pivotal role in genetic disease management, facilitating DNA extraction, library preparation, sequencing, and analysis to pinpoint genetic variants linked to diseases. For instance, as of April 2024, the Centers for Disease Control and Prevention, a US-based government agency, reported that approximately 6,000 babies are born with Down syndrome in the United States annually, occurring at a rate of about 1 in every 700 births. Hence, the escalating prevalence of genetic diseases acts as a catalyst for the expansion of the sequencing consumables market.
Leading companies in the sequencing consumables market are concentrating on the development of innovative solutions, such as human whole-genome sequencing (WGS) assays, to improve accuracy, efficiency, and speed in genomic analysis. Human whole-genome sequencing (WGS) assays entail a thorough examination of an individual's complete genome, encompassing all DNA, to detect genetic variations, mutations, and biomarkers linked to health, disease susceptibility, and response to treatment. For instance, in March 2023, Illumina Inc., a US-based biotechnology firm, introduced Illumina Complete Long Read Prep- Human, a high-performance, long-read, human whole-genome sequencing (WGS) assay. The Illumina Complete Long Read Prep, Human is compatible with Illumina NovaSeq X Plus, NovaSeq X, and NovaSeq 6000 Sequencing Systems. It grants users access to both long- and short-read data on a single Illumina instrument for the first time. This offering streamlines workflows and substantially decreases DNA input requirements compared to other long-read alternatives.
In January 2023, QIAGEN N.V., a biotechnology company based in Germany, acquired Verogen for an undisclosed amount. This acquisition aims to enhance QIAGEN's position as a leader in human identification and forensics by incorporating next-generation sequencing (NGS) technologies to improve investigative capabilities. Verogen, a US-based biotechnology firm, specializes in DNA-based human identification, sequencing products, and forensic genomic analysis.
Major companies operating in the sequencing consumables market are F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Merck KGaA, Becton Dickinson And Company, Agilent Technologies Inc, Illumina Inc, PerkinElmer Inc, Beckman Coulter Inc, Bio-Rad Laboratories Inc, QIAGEN N.V., Tecan Group AG, BGI Genomics Co Ltd, Promega Corporation, Abcam Limited, Integrated DNA Technologies Inc., Takara Bio Inc, Oxford Nanopore Technologies plc, Pacific Biosciences Of California Inc, Analytik Jena GmbH, Standard BioTools Inc, LGC Biosearch Technologies Inc., Apex Biotechnology Corp., Lexogen GmbH
North America was the largest region in the sequencing consumables market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sequencing consumables market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the sequencing consumables market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The sequencing consumables market consists of sales of enzymes, reagents, kits, buffers, and plates. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Sequencing Consumables Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses sequencing consumables market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for sequencing consumables ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The sequencing consumables market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.